Shapiro, M.D., a Mayo Clinic orthopedic physician. “Our findings can be interrupted in ways that we now need to test - one of which is that bone marrow stem cell injection in one ailing knee can relieve pain in both affected knees in a systemic or whole-body fashion,” says the study's lead author, Shane A. Tissue-specific adult stem cells that are capable of both self-renewal and specialized tissue repair reside in certain tissues, such as the epidermis. They are only able to conclude the procedure is safe to undergo as an option for knee pain, but they cannot yet recommend it for routine arthritis care. Given that the stem cell-treated knee was no better than the control-treated knee - both were dramatically better than before the study began - the researchers say the stem cells' effectiveness remains somewhat uninterpretable. Each of the 25 patients enrolled in the study had two bad knees, but did not know which knee received the stem cells. They are responsible for the repair and regeneration of tissues. The findings in The American Journal of Sports Medicine represent another first -patients not only had a dramatic improvement in the knee that received stem cells, but also in their other knee, which also had painful arthritis but received only a saline control injection. Stem cells are immature cells that can develop into various cell types in the body. offering one form of stem cell therapy or another to an estimated 100,000-plus patients, who pay thousands of dollars, out of pocket, for the treatment, which has not undergone demanding clinical study. The researchers say such testing is needed because there are at least 600 stem cell clinics in the U.S. It is the first time that the belief that stem cells can provide substantial and possible regenerative relief in an ailing joint has been put to the test in such a rigorous fashion. HSCI brings together 1000 scientists from across Harvard and its affiliated hospitals to advance stem cell biology and translational medicine in a way no. Researchers at Mayo Clinic's campus in Florida have conducted the world's first prospective, blinded and placebo-controlled clinical study to test the benefit of using bone marrow stem cells to reduce arthritic pain and disability in knees. The Pluripotent Stem Cell Facility (PSCF) supports all aspects of human pluripotent stem cell research, providing access to well characterized human.
0 Comments
Leave a Reply. |